Spravato and Vistaril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spravato (esketamine hydrochloride) and Vistaril (hydroxyzine hydrochloride). Common drug interactions include dissociation among females and disorientation among males.

The phase IV clinical study analyzes what interactions people have when they take Spravato and Vistaril. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Spravato?

Spravato has active ingredients of esketamine hydrochloride. eHealthMe is studying from 7,920 Spravato users. Check the latest studies of Spravato.

What is Vistaril?

Vistaril has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,565 Vistaril users. Check the latest studies of Vistaril.



On Jul, 13, 2026

19 people who take Spravato and Vistaril together, and have interactions are studied.

Spravato and Vistaril drug interactions.

What are the common drug interactions of Spravato and Vistaril, by gender? *:

female:

  1. Dissociation
  2. Suicidal ideation
  3. Sedation
  4. Hospitalisation
  5. Therapeutic response decreased (less preventive response)
  6. Adverse event
  7. Hypertension (high blood pressure)
  8. Drug ineffective
  9. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  10. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

male:

  1. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  2. Dizziness
  3. Dissociation
  4. Memory impairment
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting
  7. Fall
  8. Gait disturbance
  9. Loss of consciousness
  10. Sedation

What are the common drug interactions of Spravato and Vistaril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Disturbance in attention
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Hallucination (an experience involving the perception of something not present)
  6. Lacrimation increased
  7. Loss of consciousness
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Sedation
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

30-39:

  1. Hospitalisation
  2. Suicidal ideation
  3. Dissociation
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)

40-49:

  1. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  2. Dizziness
  3. Fall
  4. Gait disturbance
  5. Loss of consciousness
  6. Ligament rupture (tear in ligament)
  7. Sedation
  8. Drug ineffective
  9. Presyncope
  10. Bipolar ii disorder (characterized by at least one episode of hypomania and at least one episode of major depression)

50-59:

  1. Dissociation
  2. Sedation
  3. Adverse event
  4. Hypertension (high blood pressure)
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting
  7. Drug ineffective

60+:

  1. Dissociation
  2. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  3. Suicidal ideation

What are the existing conditions these people have? *

  1. Depression: 17 people, 89.47%
  2. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 7 people, 36.84%
  3. Sleep Disorder: 3 people, 15.79%
  4. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 15.79%
  5. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 3 people, 15.79%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
  7. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 10.53%
  8. Suicidal Ideation: 2 people, 10.53%
  9. Drowsiness: 2 people, 10.53%
  10. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Spravato and Vistaril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Spravato and Vistaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spravato:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vistaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spravato and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vistaril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on esketamine hydrochloride and hydroxyzine hydrochloride (the active ingredients of Spravato and Vistaril, respectively), and Spravato and Vistaril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: